Middle East and Africa Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
Market Introduction
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.
Get more information on this report :
Market Overview and Dynamics
The Middle East and Africa antacids market is expected to reach US$ 659.18 million in 2027 from US$ 522.04 million in 2019. The market is estimated to grow with a CAGR of 3.0% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the rise in prevalence of gastroesophageal reflux disease (GERD) and an increase in prevalence of obesity. However, the market is expected experiencing slow growth during the forecast period owing to the low awareness associated with gastrointestinal disorders in low-income economies.
Key Market Segments
Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
Major Sources and Companies Listed
Some of the major primary and secondary sources for antacids market included in the report are World Health Organization (WHO), ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014, and others.
Reasons to buy the report
- To understand the Middle East and Africa antacids market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for antacids market
- Efficiently plan M&A and partnership deals in Middle East and Africa antacids market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antacids market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East and Africa region
MIDDLE EAST AND AFRICA ANTACIDS MARKET SEGMENTATION
- Tablet
- Liquid
- Others
By Drug Class
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Magaldrate
- Sucralfate
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East and Africa
Company Profiles
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market – By Dosage Form
1.3.2 Antacid Market – By Drug Class
1.3.3 Antacid Market – By Distribution Channel
1.3.4 Middle East and Africa Antacid Market – By Country
2. Middle East and Africa Antacid Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Antacid Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antacid Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
5.1.2 Increase in Prevalence of Obesity
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Research Activities and Research Funds on GI Disorders
5.4 Future Trends
5.4.1 Rising Development of the Pharmaceutical Industry
5.5 Impact Analysis
6. Antacid Market – Middle East and Africa Analysis
6.1 Middle East and Africa Antacid Market Revenue Forecasts and Analysis
7. Middle East and Africa Antacid Market Analysis and Forecasts To 2027 – By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8. Middle East and Africa Antacid Market Analysis and Forecasts to 2027– By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.4 H Antagonist
8.4.1 Overview
8.4.2 H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9. Middle East and Africa Antacid Market Analysis and Forecasts to 2027– By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 Middle East & Africa: Antacid Market
10.1.1 Overview
10.1.2 Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
10.1.3 Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.3.3.1 Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.4 UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.4.3.1 UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.5 South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.5.3.1 South Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.6.3.1 Rest of Middle East and Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Middle East and Africa Antacid Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 2. Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 3. Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 6. UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 8. UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 12. South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. Rest of Middle East and Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Antacid Market
LIST OF FIGURES
Figure 1. Antacid Market Segmentation
Figure 2. Middle East and Africa Antacid Market Overview
Figure 3. Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market
Figure 4. Tablet Segment Held Largest Share of Dosage Form in Antacid Market
Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Antacid Market - Middle East and Africa PEST Analysis
Figure 7. Antacid Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Antacid Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 10. Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 14. Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 21. Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Middle East & Africa: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
Figure 26. Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 31. Growth Strategies Done by the Companies in the Market, (%)
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa antacids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa antacids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.